<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372308">
  <stage>Registered</stage>
  <submitdate>19/04/2017</submitdate>
  <approvaldate>26/04/2017</approvaldate>
  <actrnumber>ACTRN12617000583347</actrnumber>
  <trial_identification>
    <studytitle>Effect of smell and taste to improve nutrition in very preterm babies.</studytitle>
    <scientifictitle>Smell and taste with tube feeding to improve nutrition in very preterm infants: a randomized controlled trial.</scientifictitle>
    <utrn>U1111-1192-6122 </utrn>
    <trialacronym>TASTE trial</trialacronym>
    <secondaryid>n/a</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>prematurity</healthcondition>
    <healthcondition>growth failure</healthcondition>
    <healthcondition>milk intolerance</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>smell and taste of milk (mothers' breast milk, pasteurized donor breast milk or formula, whatever is fed at the time) with tube feeding - with every feed for the duration of the feed
&lt;32 weeks gestation until 32 weeks gestation: cotton bud soaked in milk offered for sucking and drop of milk on cotton pad placed close to the infants nose
&gt;32 weeks gestation until removal of nasogastric tube or discharge: 0.2 ml of milk given orally with a feeding syringe will will be provided</interventions>
    <comparator>Control group: routine care: no smell and taste of milk with tube feeding

Note: infants in both groups are allowed to have breast feeds/cuddles and dummies at any time.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Weight z-scores at discharge home assessed by calibrated digital scales.</outcome>
      <timepoint>Discharge home</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time (days) to full enteral feeds (120 ml/kg/d for at least 24 hours), assessed by review of feeding records.</outcome>
      <timepoint>reaching of full enteral feeds</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of parenteral nutrition (days) total assessed by chart review</outcome>
      <timepoint>from admission until discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of antibiotics (days) total, assessed by review of medical records</outcome>
      <timepoint>from admission until discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Episodes of late onset sepsis, assess by review of medical records.</outcome>
      <timepoint>discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>postmenstrual age at discharge home from hospital, assessed by review of medical records.</outcome>
      <timepoint>at discharge from hospital</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of parenteral nutrition - first episode, assessed by chart review</outcome>
      <timepoint>cessation of parenteral nutrition - first episode.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>&lt; 29 weeks postmenstrual age and/or less than 1250 g birth weight</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Days</inclusiveminagetype>
    <inclusivemaxage>14</inclusivemaxage>
    <inclusivemaxagetype>Days</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. infants with congenital conditions associated with the digestive system requiring surgery shortly after birth, e.g.: gastroschisis, any malformation requiring a stoma after birth (e.g.: anal atresia), oesophageal atresia.
2. Congenital conditions leading to impaired growth: e.g.: trisomy 21, trisomy 18, salt wasting enteropathy.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>serially numbered, sealed opaque envelopes. </concealment>
    <sequence>Block design stratified by sex and gestational age (&lt;27 weeks' PMA, &gt;= 27 weeks' PMA) in which twins and triplets will be randomized together.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Primary outcome: t-test for the significance of the difference between the means of two independent samples. The statistical analysis is based on an intention to treat analysis</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/05/2017</anticipatedstartdate>
    <actualstartdate>8/05/2017</actualstartdate>
    <anticipatedenddate>31/07/2020</anticipatedenddate>
    <actualenddate />
    <samplesize>330</samplesize>
    <actualsamplesize />
    <currentsamplesize>28</currentsamplesize>
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/12/2020</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD,VIC</recruitmentstate>
    <hospital>Mater Mother's Hospital - South Brisbane</hospital>
    <hospital>The Royal Women's Hospital - Parkville</hospital>
    <postcode>4101 - South Brisbane</postcode>
    <postcode>3052 - Parkville</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Mater Misericordiae Limited</primarysponsorname>
    <primarysponsoraddress>Raymond Terrace
South Brisbane, QLD 4101</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Mater Research </fundingname>
      <fundingaddress>Raymond Terrace
South Brisbane, QLD 4101</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Royal College of Physicians and Paediatricians - Queensland Branch</fundingname>
      <fundingaddress>Unit 20, Level 3 Royal Brisbane Place
17 Bowen Bridge Road 
Herston Qld 4006
</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>none</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Extremely premature infants do not tolerate enteral feeds well and are routinely tube fed. Our pilot trial suggests that regular smell and taste of milk with tube feeds may lead to better milk tolerance in very preterm infants, but interestingly may also increase weight z-scores at discharge, an outcome potentially relatedto better head growth and later neurodevelopmental outcomes.</summary>
    <trialwebsite>not available</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Mater Research HREC Office</ethicname>
      <ethicaddress>Raymond Terrace
South Brisbane
QLD 4101</ethicaddress>
      <ethicapprovaldate>11/04/2017</ethicapprovaldate>
      <hrec>HREC/16/MHS/112 - AM02</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Womenâ€™s Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Royal Womens Hospital, 20 Flemington Road, Parkville 3052</ethicaddress>
      <ethicapprovaldate>18/09/2017</ethicapprovaldate>
      <hrec>17/21</hrec>
      <ethicsubmitdate>23/06/2017</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Friederike Beker</name>
      <address>Neonatal Critical Care Unit
Mater Mothers' Hospital
Raymond Terrace
South Brisbane
QLD 4101</address>
      <phone>+61 7 316301955</phone>
      <fax />
      <email>friederike.beker@mater.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Friederike Beker</name>
      <address>Neonatal Critical Care Unit
Mater Mothers' Hospital
Raymond Terrace
South Brisbane
QLD 4101</address>
      <phone>+61 7 3163 1955</phone>
      <fax />
      <email>friederike.beker@mater.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Friederike Beker</name>
      <address>Neonatal Critical Care Unit
Mater Mothers' Hospital
Raymond Terrace
South Brisbane
QLD 4101</address>
      <phone>+61 7 3163 1955</phone>
      <fax />
      <email>friederike.beker@mater.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Friederike Beker</name>
      <address>Neonatal Critical Care Unit
Mater Mothers' Hospital
Raymond Terrace
South Brisbane
QLD 4101</address>
      <phone>+61 7 3163 1955</phone>
      <fax />
      <email>friederike.beker@mater.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>